We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$1.25T
AUM Growth
-$1.02T
Cap. Flow
-$1.16T
Cap. Flow %
-93.16%
Top 10 Hldgs %
19.22%
Holding
8,154
New
333
Increased
458
Reduced
6,748
Closed
331

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$50.9B
2
AAPL icon
Apple
AAPL
+$38.9B
3
AMZN icon
Amazon
AMZN
+$26B
4
NVDA icon
NVIDIA
NVDA
+$23.3B
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$17B

Sector Composition

Rank Sector Weight
1 Technology 21.37%
2 Financials 10.81%
3 Healthcare 9.76%
4 Consumer Discretionary 9.08%
5 Industrials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKTX
7551
Akari Therapeutics
AKTX
$13.8M
0
EPV icon
7552
ProShares UltraShort FTSE Europe
EPV
$11.1M
0
EVNT icon
7553
AltShares Event-Driven ETF
EVNT
$12.6M
$11 ﹤0.01%
+1
New +$10
KROP icon
7554
Global X AgTech & Food Innovation ETF
KROP
$9.17M
0
PILL icon
7555
Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
$20.7M
$11 ﹤0.01%
1
-1
-50% -$8
RDCM icon
7556
Radcom
RDCM
$171M
$11 ﹤0.01%
1
-1
-50% -$10
SONN
7557
DELISTED
Sonnet BioTherapeutics
SONN
$11 ﹤0.01%
1
-14
-93% -$188
XOSWW
7558
Xos Inc Warrants
XOSWW
$17K
$11 ﹤0.01%
357
-357
-50% -$9
MACA
7559
DELISTED
Moringa Acquisition Corp Class A Ordinary Shares
MACA
$11 ﹤0.01%
1
-1
-50% -$11
FATBB
7560
DELISTED
FAT Brands
FATBB
$10 ﹤0.01%
2
-1
-33% -$4
RPHS
7561
DELISTED
Regents Park Hedged Market Strategy ETF
RPHS
$10 ﹤0.01%
+1
New +$9
RXD icon
7562
ProShares UltraShort Health Care
RXD
$3.23M
$10 ﹤0.01%
+1
New +$22
TNON icon
7563
Tenon Medical
TNON
$3.44M
$10 ﹤0.01%
1
-2
-67% -$20
BITE.U
7564
DELISTED
Bite Acquisition Corp. Units, each consisting of one share of common stock, and one-half of one redeemable warrant
BITE.U
$10 ﹤0.01%
1
-1
-50% -$11
CONXU
7565
DELISTED
CONX Corp. Unit
CONXU
$10 ﹤0.01%
1
-1
-50% -$11
RYM
7566
RYTHM Inc
RYM
$39.5M
$9 ﹤0.01%
2
-1
-33% -$10
CELG.RT
7567
Bristol-Myers Squibb Rights
CELG.RT
$191M
$9 ﹤0.01%
164
-164
-50% -$10
CLGN icon
7568
CollPlant Biotechnologies
CLGN
$5.16M
$9 ﹤0.01%
1
-1
-50% -$5
MNYWW
7569
MoneyHero Ltd Warrants
MNYWW
$855K
$9 ﹤0.01%
80
-80
-50% -$6
FEED
7570
ENvue Medical Inc
FEED
$1.92M
0
PMCB icon
7571
PharmaCyte Biotech
PMCB
$6.18M
$9 ﹤0.01%
3
-5
-63% -$11
QDROW
7572
DELISTED
Quadro Acquisition One Corp. Warrant
QDROW
$9 ﹤0.01%
266
-266
-50% -$12
DALT
7573
DELISTED
Anfield Diversified Alternatives ETF
DALT
$9 ﹤0.01%
+1
New +$9
HDRO
7574
DELISTED
Defiance Next Gen H2 ETF
HDRO
0
KLNE
7575
DELISTED
Direxion Daily Global Clean Energy Bull 2X Shares
KLNE
$8 ﹤0.01%
1
-3
-75% -$21

Similar funds

Morgan Stanley's Q1 2024 Portfolio in Review

As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 331 positions and reducing 6,748 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.

  • Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
  • Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
  • Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
  • Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
  • Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
  • Morgan Stanley opened 333 new positions and closed 331 in Q1 2024.
  • Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.